Ana Luiza Maia
Ana Luiza Maia, MD, PhD, received her Medical degree at the Universidade Federal da Bahia, Salvador, Brazil. Soon after her graduation (1986), she moved to Ribeirão Preto, São Paulo, where she did her residency training and clinical fellowship in Endocrinology (1987-89), at the Hospital de Clínicas da Faculdade de Medicina, University of São Paulo. After obtained her Master of Science at the same Institution (1991), she applied for a PhD-sandwich program at the Harvard Medical School, Boston, USA, under the supervision of P Reed Larsen. Dr. Maia obtained her PhD degree in 1994, after presenting her thesis focused on the molecular mechanisms of type 1 deiodinase-catalyzed thyroid hormone deiodination, but continued her studies at the Thyroid Division, Brigham and Women’s Hospital, Boston, as a post-doc research fellow until 1995, when she returned to Brazil to join the Endocrinology Division at the Medical School, Universidade Federal do Rio Grande do Sul (UFRGS), as Associated Professor of Medicine (1997). At that time, as chief of the Thyroid Section, Hospital de Clinicas de Porto Alegre (HCPA), she set up a molecular laboratory and implemented the genetic diagnosis of Multiple Endocrine Neoplasia Type 2, thenceforth considered as a reference Center to diagnostic and treatment of medullary thyroid carcinoma. In 2003, she returned to Boston for a 2-year sabbatical, as a Visiting Associate Professor at Harvard Medical School, where she studied the role of deiodinases in human T3 production.
Dr. Maia has published over 100 original papers and reviews in peer-reviewed top-ranked journals (Curriculum Lattes). Besides her contribution for thyroid research, she has been very active in graduate and post-graduated programs, working in several committees and supervising post-graduate (PhD and MSc) and undergraduate students. Dr. Maia has also an active role at the Brazilian Endocrine Society, being the past president of the Thyroid Department (2002-2005) and elected member of the board of Directors for several times. She has coordinated the Brazilian guidelines of Diagnosis and Treatment of Thyroid Nodules and Differentiated Carcinomas (2007), Hyperthyroidism (2013), and Medullary Thyroid Carcinomas (2014). In LATS, Dr. Maia has served several times as an elected-member of the Executive and Scientific Committee and was a LATS representative in the Program Organizing Committee (POC) of the 13th International Thyroid Congress (2001-05). She is also a member of American Thyroid Association (ATA) and Endocrine Society, where she has served as member of the Annual Meeting Steering Committee (2015-17).
Dr. Maia is currently a Full Professor of Medicine (UFRGS) and chief of the Thyroid Unit, HCPA. She continues interested in basic and clinical aspects of the thyroid hormone physiology, particularly on the role of deiodinases in human diseases. She also coordinates several studies on the molecular and clinical aspects of medullary and differentiated thyroid carcinomas. Among the numerous awards received include Award is Knoll - Young Investigator Award Prof. Thales Martins, LATS-Young Investigator Prize and Fogarty International Research Collaboration Award (FIRCA). She has also awarded by grants from national (PRONEX, CNPq, FAPERGS, FIFE/HCPA) and international (NIH) agencies. She is a research investigator (1995- ) and has recently served as an-elected member and Coordinator of the Advisory Committee on Medicine (2012-15) on the Brazilian National Research Council (CNPq).